NIFTY® Test Pro builds on the standard NIFTY® Test and provides expanded screening options covering all chromosomal numeric aneuploidies and 84 kinds of microdeletion/duplication syndromes.

• Comprehensive – 84 kinds of microdeletion and microduplication syndromes including Di George Syndrome

• Accurate – with 25M data size, increased analytic quality

• Safe – no risk of miscarriage

• Early – screen from week 10 of pregnancy



• Fast – results delivered in under 10 working days

Note: This information is for qualified healthcare providers only and is for informational purposes only. The NIFTY test is considered a screening test, not a diagnostic test and therefore false positive and false negative results can occur. NIFTY does not screen for potential chromosomal or genetic conditions other than those expressly identified. Before making any treatment decisions, all women should discuss their results with their healthcare provider, who can recommend confirmatory, diagnostic testing where appropriate. This testing service has not been cleared or approved by the US FDA and is not available in the USA.